Percentage of patients aged 18 years and older with a diagnosis of multiple myeloma, not in remission, who were prescribed or received intravenous bisphosphonate therapy within the 12 month reporting period
This measure is to be submitted a minimum of once per performance period for all multiple myeloma (not in remission) patients seen during the performance period. It is anticipated that eligible clinicians who provide services for the patients with the diagnosis of multiple myeloma (not in remission) will submit this measure.
NOTE: No notes related
The listed denominator criteria is used to identify the intended patient population. The numerator options included in this specification are used to submit the quality actions allowed by the measure. The quality-data codes listed do not need to be submitted for registry submissions; however, these codes may be submitted for those registries that utilize claims data.
Patients who were prescribed or received intravenous bisphosphonate therapy within the 12 month reporting period
Bisphosphonate Therapy – Includes the following medications: pamidronate and zoledronate.
Prescribed – Includes patients who are currently receiving medication(s) that follow the treatment plan recommended at an encounter during the performance period, even if the prescription for that medication was ordered prior to the encounter.
Numerator Quality-Data Coding Options
Documentation of iron stores prior to initiating erythropoietin therapy (3160F)
Documentation of system reason(s) for not documentingiron stores prior to initiating erythropoietin therapy(3160F with 3P)
Performance Not Met:
Iron stores prior to initiating erythropoietin therapy not documented, reason not otherwise specified (3160F with 8P)
NUMERATOR NOTE: Denominator Exception(s) are determined on the date of the denominator eligible encounter.
All patients aged 18 years and older with a diagnosis of multiple myeloma, not in remission
Eligible cases are determined, and must be reported, if either of the following conditions
DENOMINATOR NOTE: *Signifies that this CPT Category I code is a non-covered service under the Medicare Part B Physician Fee Schedule (PFS). These non-covered services should be counted in the denominator population for registry-based measures
Denominator Criteria (Eligible Cases):
Patients aged ≥ 18 years on date of encounter
Diagnosis for multiple myeloma – not in remission (ICD-10-CM): C90.00, C90.02
Patient encounter during the performance period (CPT): 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99241*, 99242*, 99243*, 99244*, 99245*
Telehealth Modifier: GQ, GT, 95, POS 02